ATG5 and head and neck squamous cell carcinoma: Polymorphism ATG5 rs2245214 has been previously studied in patients with head and neck squamous cell carcinoma [29], non-medullary thyroid cancer [31], Paget disease of bone [32], tuberculosis [33] and lupus erythematous [34] with heterogeneous results.